vimarsana.com

Page 10 - Autonomous Institute News Today : Breaking News, Live Updates & Top Stories | Vimarsana

DBT-NII Receives Trademark for India s First Indigenous Tumour Antigen SPAG9 – India Education | Latest Education News | Global Educational News

UP University Exams 2021 Update; Under Graduate (UG) First And Second Year Students Will Be Promoted | UG फर्स्ट और सेकेंड इयर के स्टूडेंट्स प्रमोट होंगे, PG में सिर्फ फाइनल इयर की परीक्षा होगी

UP University Exams 2021 Update; Under Graduate (UG) First And Second Year Students Will Be Promoted | UG फर्स्ट और सेकेंड इयर के स्टूडेंट्स प्रमोट होंगे, PG में सिर्फ फाइनल इयर की परीक्षा होगी
bhaskar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bhaskar.com Daily Mail and Mail on Sunday newspapers.

Bihar government is preparing to build four new universities - बिहार सरकार कर रही है चार नई यूनिवर्सिटी बनाने की तैयारी

Bihar government is preparing to build four new universities - बिहार सरकार कर रही है चार नई यूनिवर्सिटी बनाने की तैयारी
livehindustan.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from livehindustan.com Daily Mail and Mail on Sunday newspapers.

Q BioMed s Uttroside-B Receives Additional Patent Coverage in Canada and Japan

Published: Jan 26, 2021   NEW YORK, Jan. 26, 2021 /PRNewswire/ Q Biomed Inc. (OTCQB: QBIO), announces that it has received additional notices of patent allowances from both Canada and Japan for its Uttroside-B molecule intended to treat liver cancer. The patent titled Uttroside-B and Derivatives Thereof as Therapeutics for Hepatocellular Carcinoma is a Method Of Use patent that covers the use of Uttroside-B for the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer. International and additional U.S. claims are currently under prosecution for the technology which addresses a severe unmet need for a safe and effective drug to treat HCC.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.